Leen Kawas is the President and CEO of Athira Pharma. Read the Q&A below to learn more about why she chose to study Alzheimer’s and how she co-founded Athira. Today, I am the president and CEO of Athira Pharma, a company that I co-founded after my graduate studies, focused on a new approach to Alzheimer’s […]

Tonix Pharmaceuticals is opening an early-stage antiviral asset deal with OyaGen as the pair targets COVID-19. The research and license pact, financials of which were not made public, focuses on the antiviral inhibitor of SARS-CoV-2, TNX-3500 (aka sangivamycin, formerly OYA1), which Tonix believes can hit back against the pandemic virus and “potentially other viral disorders.” […]

This episode features an amazing Guru! Dr. Loew, she has some amazing experience integrating science, business and the clinician  to deliver differentiated value to patients. Most recently, she was Vice President, Head R&D Strategy and Planning at BristolMyers Squibb where she led portfolio strategy and operations. This included shaping BMS’s strategy and portfolio to deliver […]